Posts Tagged ‘Baycol’
America’s Healthcare Crisis–Part II–What Do We Get for $$$ ?
Part II. What Do We Get for All That Money? A preventable epidemic of injury and death from prescription drugs; FDA’s contribution to the epidemic; Big Pharma’s business model: manufactured myths, propaganda and a hidden agenda;
US Healthcare Third Leading Cause of Death_Barbara Starfield, MD
Why didn’t Barbara Starfield’s Findings (JAMA 2000) cause a major overhaul of US medicine?
Read More
Rx Drugs Recalled for Safety Issues from US market
List of FDA-licensed prescription drugs withdrawn from US market for safety issues:
Between 1973 and 1991 (18 years) —16 drugs were withdrawan; Between 1992 and 2011 (19 years)—28 drugs were withdrawn.
Lies, Damned Lies, and Medical Science
A fascinating article in The Atlantic, "Lies, Damned Lies, and Medical Science" by David Freedman, profiles Dr. John Ioannidis, who says that as much as 90% of the published medical information that doctors rely on is flawed.
Read MoreFDA Approves Crestor Use for Healthy People–Watch Healthcare Costs Skyrocket
"500 people would need to be treated with Crestor for a year to avoid one usually survivable heart attack. Stroke numbers were similar…At $3.50 a pill, the cost of prescribing Crestor to 500 people for a year would be $638,000 to prevent one heart attack."
Read MoreBayer Settles Baycol AG Stuits $8 million
Repeat legal violations: The record of recidivism by major drug manufacturers is a matter of public record.
Read MoreRole of Litigation in Defining Drug Risks_JAMA / BMJ
Documents uncovered during the course of litigation shed light on real risks of drug-induced harm that would not otherwise be known.
Read MoreDangerous Deception: Hiding the Evidence of Adverse Drug Effects_NEJM
FDA's slip-shod approval of defective, harmful drugs, accompanied by rubber stampped endorsements by compromised FDA advisory committees may be reaching a boiling point.
Read MorePublic Servant or Private Marketer? NIH Seeks Inquiry of Alzheimer’s researcher conflicts of interest
NIH: Public Servant or Private Marketer? NIH Seeks Outside Inquiry of Alzheimer’s researcher conflicts of interest – LAT Mon, 31 Jan 2005 A year after the Los Angeles Times published its first an in-depth investigative report documenting in detail evidence of major conflicts of interest by top scientists at the National Institutes of Health, [December…
Read MoreBayer/ Baycol on Trial in Texas – NYT
Bayer/ Baycol on Trial in Texas_NYT Sat, 1 Mar 2003 Melody Peterson of the New York Times reports that in the first case brought against Bayer involving its anticholesterol drug, Baycol, a senior official of Bayer AG testified in court in Corpus Cristi, Texas. He acknowledged that company officials in Germany proceeded with the marketing…
Read MoreCash Interests Taint Drug Advice – NATURE / Death a Risk of Antipsychotics – AP
Cash Interests Taint Drug Advice – NATURE / Death a Risk of Antipsychotics – AP Sun, 23 Oct 2005 An investigation by the journal, NATURE (the largest of its kind) reveals that not only do conflicts of interest taint the conduct and outcome of clinical trials, the authors who formulate clinical practice guidelines have financial…
Read MoreCalls Mounting for FDA Revamp / Americans Are the most medicated population in the world – DHHS
Calls Mounting for FDA Revamp / Americans Are the most medicated population in the world – DHHS Sun, 26 Dec 2004 A government survey by the U.S. Department of Health and Human Services, confirms that Americans are the most medicated population in the world – 44 percent of Americans had taken at least one prescription…
Read More